Medication info

Dongkwang Cimetidine Injection

Prescription medicationInjectionsIntravenous injectionExpired
Ingredient · strength
Cimetidine›200mg / 1 ampoule
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
A colorless or pale yellow transparent solution in a colorless transparent ampoule injection.
Packaging
50 ampoules/box [(2 milliliters/ampoule)]
Approval status
Expired

MFDS item code 201506742 · Notified 2015.09.24 · Insurance code 645905911

This product's status changed to Expired on 2025.09.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of upper gastrointestinal bleeding (e.g., peptic ulcers) and Zollinger-Ellison syndrome
Who receives it
Adults · Children
Adult administration
Adults 1) Intravenous injection Administer 200 mg of cimetidine intravenously every 4 〜 6 hours. Do not exceed 2 g per day. 2) Intravenous infusion Administer 200 mg of this medicine by intravenous infusion over 2 hours every 4 〜 6 hours. The maximum infusion rate must not exceed 150 mg per hour or 2 mg/kg body weight/hr. For continuous intravenous infusion, the average infusion rate should preferably not exceed 75 mg per hour over 24 hours, and the maximum daily infusion amount must not exceed 2 g. Etchtoomix Injection (cimetidine hydrochloride) (JW Pharmaceutical) Adults: Administer 300 mg of cimetidine by intravenous infusion over 15 〜 20 minutes every 6 〜 8 hours. If the dose needs to be increased, repeat 300 mg doses as needed, not exceeding 2,400 mg per day.
Child administration
Children: Administer 20 〜 40 mg/kg body weight per day by divided intravenous doses. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of upper gastrointestinal bleeding (e.g., peptic ulcers) and Zollinger-Ellison syndrome

  • Zollinger-Ellison syndrome
  • upper gastrointestinal bleeding
  • peptic ulcer
  • acute stress ulcer
  • hemorrhagic gastritis.
View approved original text

This medication is used for Zollinger-Ellison syndrome and upper gastrointestinal bleeding, particularly peptic ulcers, acute stress ulcers, and hemorrhagic gastritis.

How it is given

Adult administration

Adults 1) Intravenous injection Administer 200 mg of cimetidine intravenously every 4 〜 6 hours. Do not exceed 2 g per day. 2) Intravenous infusion Administer 200 mg of this medicine by intravenous infusion over 2 hours every 4 〜 6 hours. The maximum infusion rate must not exceed 150 mg per hour or 2 mg/kg body weight/hr. For continuous intravenous infusion, the average infusion rate should preferably not exceed 75 mg per hour over 24 hours, and the maximum daily infusion amount must not exceed 2 g. Etchtoomix Injection (cimetidine hydrochloride) (JW Pharmaceutical) Adults: Administer 300 mg of cimetidine by intravenous infusion over 15 〜 20 minutes every 6 〜 8 hours. If the dose needs to be increased, repeat 300 mg doses as needed, not exceeding 2,400 mg per day.

Child administration

Children: Administer 20 〜 40 mg/kg body weight per day by divided intravenous doses. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication is provided in glass ampoule form, so it must be carefully cut to avoid glass fragments mixing in before use. Extreme caution is especially needed when administering it to children and the elderly. Patients with a history of allergy or hypersensitivity reactions to this drug, as well as those taking dofetilide, should not be administered this medication. The use of dofetilide together may increase the risk of cardiac arrhythmias. Patients with impaired kidney or liver function, those with a drug allergy history, the elderly, children under 19 years old, and patients undergoing hemodialysis may require dose adjustment or changes in administration intervals, and because gastric cancer symptoms may be masked, it is necessary to verify malignancy before administration. Patients with peptic ulcers infected by Helicobacter pylori should also undergo bacterial eradication therapy. This drug can cause various side effects, including decreased blood cell counts, liver dysfunction, renal impairment, allergic reactions, endocrine dysfunction, gastrointestinal symptoms, neurological symptoms, cardiovascular anomalies, skin reactions; therefore, if any abnormal symptoms occur, medical personnel should be notified immediately. During treatment, the course of the disease should be monitored closely, and if there is no effect, a change to another treatment method should be considered. Additionally, blood, liver, and kidney function tests should be conducted regularly to check for abnormalities. The elderly, those with chronic illnesses, and immunocompromised patients may have an increased risk of pneumonia when taking this medication; hence caution is advised. There may also be interactions with other medications, such as coumarin anticoagulants, so administration should be discussed with health professionals. Women who are pregnant or may become pregnant should carefully consider the administration of this medication as its effects on the fetus are not fully understood. In nursing mothers, this drug may be excreted in breast milk, so it is advisable to discontinue breastfeeding. In children, safety has not been sufficiently confirmed, so it should only be used when the therapeutic benefits outweigh the risks. In cases of overdose, serious side effects such as respiratory depression may occur, necessitating immediate emergency care. When administered as an injection, there is a risk of arrhythmias or hypotension resulting from rapid intravenous injection, so slow injection is safer. Finally, this medication should be stored out of reach of children, and transferring it to another container should be avoided as it may lead to accidents and degradation of quality.

Side effects

  • leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • generalized weakness
  • asthenia
  • subcutaneous hemorrhage
  • mucosal hemorrhage
Show 50 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
  • elevated ALT
  • hepatic fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactic-like reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • excessive milk secretion
  • increased vaginal discharge
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • convulsion
  • limb numbness
  • stiffness
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • confusion state
  • bradycardia
  • tachycardia
  • palpitations
  • ventricular block
  • mucosal skin syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • generalized heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that does not come into contact with air, preferably at room temperature between 1 and 30 degrees Celsius. Storing it this way will maintain the effectiveness of the drug and prevent degradation.

Appearance and packaging

Appearance

A colorless or pale yellow transparent solution in a colorless transparent ampoule injection.

Package unit

50 ampoules/box [(2 milliliters/ampoule)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.